Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Avidity Biosciences Inc RNA

Healthcare Biotechnology
Avidity Biosciences, Inc. is a biopharmaceutical company. The Company is engaged in delivering a new class of ribonucleic acid (RNA) therapeutics called antibody oligonucleotide conjugates (AOCs). The AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:RNA)

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire 1 day ago

Avidity Biosciences to Participate in Upcoming Investor Conference

PR Newswire November 26, 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire November 21, 2024

Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations

PR Newswire November 12, 2024

Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights

PR Newswire November 7, 2024

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024

PR Newswire October 31, 2024

Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE(TM) Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy

PR Newswire October 30, 2024

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PR Newswire October 21, 2024

Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)

PR Newswire October 3, 2024
View More News ››

Opinion & Analysis (NDAQ:RNA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RNA)

Avidity Biosciences Reports Second Quarter 2024 Financial Re

Breaking News: $RNA Avidity Biosciences Reports Second Quarter 2024 Financial Results and Recent HighlightsAvidity Biosciences Reports...
whytestocks - August 9, 2024

Avidity Biosciences Announces Positive AOC 1044 Data Demonst

Breaking News: $RNA Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin...
whytestocks - August 9, 2024

Avidity Biosciences, Inc. (NASDAQ:RNA): Pioneering the Next

http://beyondspx.com/2024/08/02/avidity-biosciences-inc-nasdaqrna-pioneering-the-next-generation-of-rna-therapeutics/
MikeTester - August 3, 2024

Casey's Reports Upbeat Earnings, Joins Avidity Biosciences,

JUST IN: $RNA Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On...
whytestocks - June 12, 2024

RNA ..... Scalped ... Yehha !

cheers 
Iseneschal - December 14, 2022

RNA ....vols are increasing

Needs to break $18 and this will be heroic !
Iseneschal - December 14, 2022
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »